Global Histone Deacetylase (HDAC) Inhibitors Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Histone Deacetylase (HDAC) Inhibitors Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Histone Deacetylase (HDAC) Inhibitors by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Histone Deacetylase (HDAC) Inhibitors by Country/Region, 2017, 2022 & 2028

2.2 Histone Deacetylase (HDAC) Inhibitors Segment by Type

2.2.1 Hydroxamic Acids

2.2.2 Cyclic Tetrapeptides

2.2.3 Benzamides

2.2.4 Electrophilic Ketones

2.2.5 Aliphatic Acid

2.3 Histone Deacetylase (HDAC) Inhibitors Sales by Type

2.3.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2017-2022)

2.3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Type (2017-2022)

2.3.3 Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Type (2017-2022)

2.4 Histone Deacetylase (HDAC) Inhibitors Segment by Application

2.4.1 Psychiatry and Neurology

2.4.2 Cancer Treatment

2.4.3 HIV

2.4.4 Others

2.5 Histone Deacetylase (HDAC) Inhibitors Sales by Application

2.5.1 Global Histone Deacetylase (HDAC) Inhibitors Sale Market Share by Application (2017-2022)

2.5.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue and Market Share by Application (2017-2022)

2.5.3 Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Application (2017-2022)

3 Global Histone Deacetylase (HDAC) Inhibitors by Company

3.1 Global Histone Deacetylase (HDAC) Inhibitors Breakdown Data by Company

3.1.1 Global Histone Deacetylase (HDAC) Inhibitors Annual Sales by Company (2020-2022)

3.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Company (2020-2022)

3.2 Global Histone Deacetylase (HDAC) Inhibitors Annual Revenue by Company (2020-2022)

3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Company (2020-2022)

3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Company (2020-2022)

3.3 Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Company

3.4 Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Product Location Distribution

3.4.2 Players Histone Deacetylase (HDAC) Inhibitors Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Histone Deacetylase (HDAC) Inhibitors by Geographic Region

4.1 World Historic Histone Deacetylase (HDAC) Inhibitors Market Size by Geographic Region (2017-2022)

4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Annual Revenue by Geographic Region

4.2 World Historic Histone Deacetylase (HDAC) Inhibitors Market Size by Country/Region (2017-2022)

4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Annual Sales by Country/Region (2017-2022)

4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Annual Revenue by Country/Region

4.3 Americas Histone Deacetylase (HDAC) Inhibitors Sales Growth

4.4 APAC Histone Deacetylase (HDAC) Inhibitors Sales Growth

4.5 Europe Histone Deacetylase (HDAC) Inhibitors Sales Growth

4.6 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Growth

5 Americas

5.1 Americas Histone Deacetylase (HDAC) Inhibitors Sales by Country

5.1.1 Americas Histone Deacetylase (HDAC) Inhibitors Sales by Country (2017-2022)

5.1.2 Americas Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2017-2022)

5.2 Americas Histone Deacetylase (HDAC) Inhibitors Sales by Type

5.3 Americas Histone Deacetylase (HDAC) Inhibitors Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Histone Deacetylase (HDAC) Inhibitors Sales by Region

6.1.1 APAC Histone Deacetylase (HDAC) Inhibitors Sales by Region (2017-2022)

6.1.2 APAC Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2017-2022)

6.2 APAC Histone Deacetylase (HDAC) Inhibitors Sales by Type

6.3 APAC Histone Deacetylase (HDAC) Inhibitors Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Histone Deacetylase (HDAC) Inhibitors by Country

7.1.1 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2017-2022)

7.1.2 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2017-2022)

7.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Type

7.3 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors by Country

8.1.1 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2017-2022)

8.1.2 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2017-2022)

8.2 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Type

8.3 Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Histone Deacetylase (HDAC) Inhibitors

10.3 Manufacturing Process Analysis of Histone Deacetylase (HDAC) Inhibitors

10.4 Industry Chain Structure of Histone Deacetylase (HDAC) Inhibitors

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Histone Deacetylase (HDAC) Inhibitors Distributors

11.3 Histone Deacetylase (HDAC) Inhibitors Customer

12 World Forecast Review for Histone Deacetylase (HDAC) Inhibitors by Geographic Region

12.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size Forecast by Region

12.1.1 Global Histone Deacetylase (HDAC) Inhibitors Forecast by Region (2023-2028)

12.1.2 Global Histone Deacetylase (HDAC) Inhibitors Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Histone Deacetylase (HDAC) Inhibitors Forecast by Type

12.7 Global Histone Deacetylase (HDAC) Inhibitors Forecast by Application

13 Key Players Analysis

13.1 Gloucester Pharmaceuticals

13.1.1 Gloucester Pharmaceuticals Company Information

13.1.2 Gloucester Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Offered

13.1.3 Gloucester Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Gloucester Pharmaceuticals Main Business Overview

13.1.5 Gloucester Pharmaceuticals Latest Developments

13.2 Spectrum Pharmaceuticals

13.2.1 Spectrum Pharmaceuticals Company Information

13.2.2 Spectrum Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Offered

13.2.3 Spectrum Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Spectrum Pharmaceuticals Main Business Overview

13.2.5 Spectrum Pharmaceuticals Latest Developments

13.3 Pharmacyclics

13.3.1 Pharmacyclics Company Information

13.3.2 Pharmacyclics Histone Deacetylase (HDAC) Inhibitors Product Offered

13.3.3 Pharmacyclics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pharmacyclics Main Business Overview

13.3.5 Pharmacyclics Latest Developments

13.4 Roche (Ventana Medical Systems)

13.4.1 Roche (Ventana Medical Systems) Company Information

13.4.2 Roche (Ventana Medical Systems) Histone Deacetylase (HDAC) Inhibitors Product Offered

13.4.3 Roche (Ventana Medical Systems) Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Roche (Ventana Medical Systems) Main Business Overview

13.4.5 Roche (Ventana Medical Systems) Latest Developments

13.5 Signal Rx

13.5.1 Signal Rx Company Information

13.5.2 Signal Rx Histone Deacetylase (HDAC) Inhibitors Product Offered

13.5.3 Signal Rx Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Signal Rx Main Business Overview

13.5.5 Signal Rx Latest Developments

13.6 SpeBio

13.6.1 SpeBio Company Information

13.6.2 SpeBio Histone Deacetylase (HDAC) Inhibitors Product Offered

13.6.3 SpeBio Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 SpeBio Main Business Overview

13.6.5 SpeBio Latest Developments

13.7 Quimatryx

13.7.1 Quimatryx Company Information

13.7.2 Quimatryx Histone Deacetylase (HDAC) Inhibitors Product Offered

13.7.3 Quimatryx Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Quimatryx Main Business Overview

13.7.5 Quimatryx Latest Developments

13.8 TetraLogic Pharmaceuticals

13.8.1 TetraLogic Pharmaceuticals Company Information

13.8.2 TetraLogic Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Offered

13.8.3 TetraLogic Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 TetraLogic Pharmaceuticals Main Business Overview

13.8.5 TetraLogic Pharmaceuticals Latest Developments

13.9 Onyx

13.9.1 Onyx Company Information

13.9.2 Onyx Histone Deacetylase (HDAC) Inhibitors Product Offered

13.9.3 Onyx Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Onyx Main Business Overview

13.9.5 Onyx Latest Developments

13.10 Mirati Therapeutics

13.10.1 Mirati Therapeutics Company Information

13.10.2 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Offered

13.10.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mirati Therapeutics Main Business Overview

13.10.5 Mirati Therapeutics Latest Developments

13.11 Karus Therapeutics

13.11.1 Karus Therapeutics Company Information

13.11.2 Karus Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Offered

13.11.3 Karus Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Karus Therapeutics Main Business Overview

13.11.5 Karus Therapeutics Latest Developments

14 Research Findings and Conclusion

Table 1. Histone Deacetylase (HDAC) Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Histone Deacetylase (HDAC) Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hydroxamic Acids

Table 4. Major Players of Cyclic Tetrapeptides

Table 5. Major Players of Benzamides

Table 6. Major Players of Electrophilic Ketones

Table 7. Major Players of Aliphatic Acid

Table 8. Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2017-2022)

Table 10. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2017-2022) & ($ million)

Table 11. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2017-2022)

Table 12. Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2017-2022)

Table 15. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2017-2022)

Table 16. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2017-2022)

Table 17. Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Histone Deacetylase (HDAC) Inhibitors Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Company (2020-2022)

Table 20. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Company (2020-2022)

Table 22. Global Histone Deacetylase (HDAC) Inhibitors Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Histone Deacetylase (HDAC) Inhibitors Producing Area Distribution and Sales Area

Table 24. Players Histone Deacetylase (HDAC) Inhibitors Products Offered

Table 25. Histone Deacetylase (HDAC) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Histone Deacetylase (HDAC) Inhibitors Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share Geographic Region (2017-2022)

Table 30. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Histone Deacetylase (HDAC) Inhibitors Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country/Region (2017-2022)

Table 34. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Histone Deacetylase (HDAC) Inhibitors Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2017-2022)

Table 38. Americas Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2017-2022)

Table 40. Americas Histone Deacetylase (HDAC) Inhibitors Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2017-2022)

Table 42. Americas Histone Deacetylase (HDAC) Inhibitors Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2017-2022)

Table 44. APAC Histone Deacetylase (HDAC) Inhibitors Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2017-2022)

Table 46. APAC Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2017-2022)

Table 48. APAC Histone Deacetylase (HDAC) Inhibitors Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2017-2022)

Table 50. APAC Histone Deacetylase (HDAC) Inhibitors Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2017-2022)

Table 52. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2017-2022)

Table 54. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2017-2022)

Table 56. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2017-2022)

Table 58. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Histone Deacetylase (HDAC) Inhibitors

Table 69. Key Market Challenges & Risks of Histone Deacetylase (HDAC) Inhibitors

Table 70. Key Industry Trends of Histone Deacetylase (HDAC) Inhibitors

Table 71. Histone Deacetylase (HDAC) Inhibitors Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Histone Deacetylase (HDAC) Inhibitors Distributors List

Table 74. Histone Deacetylase (HDAC) Inhibitors Customer List

Table 75. Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Forecast by Region

Table 77. Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Histone Deacetylase (HDAC) Inhibitors Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Histone Deacetylase (HDAC) Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share Forecast by Application (2023-2028)

Table 95. Gloucester Pharmaceuticals Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 96. Gloucester Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 97. Gloucester Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Gloucester Pharmaceuticals Main Business

Table 99. Gloucester Pharmaceuticals Latest Developments

Table 100. Spectrum Pharmaceuticals Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 101. Spectrum Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 102. Spectrum Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Spectrum Pharmaceuticals Main Business

Table 104. Spectrum Pharmaceuticals Latest Developments

Table 105. Pharmacyclics Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 106. Pharmacyclics Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 107. Pharmacyclics Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Pharmacyclics Main Business

Table 109. Pharmacyclics Latest Developments

Table 110. Roche (Ventana Medical Systems) Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 111. Roche (Ventana Medical Systems) Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 112. Roche (Ventana Medical Systems) Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Roche (Ventana Medical Systems) Main Business

Table 114. Roche (Ventana Medical Systems) Latest Developments

Table 115. Signal Rx Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 116. Signal Rx Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 117. Signal Rx Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Signal Rx Main Business

Table 119. Signal Rx Latest Developments

Table 120. SpeBio Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 121. SpeBio Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 122. SpeBio Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. SpeBio Main Business

Table 124. SpeBio Latest Developments

Table 125. Quimatryx Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 126. Quimatryx Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 127. Quimatryx Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Quimatryx Main Business

Table 129. Quimatryx Latest Developments

Table 130. TetraLogic Pharmaceuticals Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 131. TetraLogic Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 132. TetraLogic Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. TetraLogic Pharmaceuticals Main Business

Table 134. TetraLogic Pharmaceuticals Latest Developments

Table 135. Onyx Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 136. Onyx Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 137. Onyx Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Onyx Main Business

Table 139. Onyx Latest Developments

Table 140. Mirati Therapeutics Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 141. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 142. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Mirati Therapeutics Main Business

Table 144. Mirati Therapeutics Latest Developments

Table 145. Karus Therapeutics Basic Information, Histone Deacetylase (HDAC) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 146. Karus Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Offered

Table 147. Karus Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Karus Therapeutics Main Business

Table 149. Karus Therapeutics Latest Developments

List of Figures

Figure 1. Picture of Histone Deacetylase (HDAC) Inhibitors

Figure 2. Histone Deacetylase (HDAC) Inhibitors Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Histone Deacetylase (HDAC) Inhibitors Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Histone Deacetylase (HDAC) Inhibitors Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hydroxamic Acids

Figure 10. Product Picture of Cyclic Tetrapeptides

Figure 11. Product Picture of Benzamides

Figure 12. Product Picture of Electrophilic Ketones

Figure 13. Product Picture of Aliphatic Acid

Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type in 2021

Figure 15. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2017-2022)

Figure 16. Histone Deacetylase (HDAC) Inhibitors Consumed in Psychiatry and Neurology

Figure 17. Global Histone Deacetylase (HDAC) Inhibitors Market: Psychiatry and Neurology (2017-2022) & (K Pcs)

Figure 18. Histone Deacetylase (HDAC) Inhibitors Consumed in Cancer Treatment

Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Market: Cancer Treatment (2017-2022) & (K Pcs)

Figure 20. Histone Deacetylase (HDAC) Inhibitors Consumed in HIV

Figure 21. Global Histone Deacetylase (HDAC) Inhibitors Market: HIV (2017-2022) & (K Pcs)

Figure 22. Histone Deacetylase (HDAC) Inhibitors Consumed in Others

Figure 23. Global Histone Deacetylase (HDAC) Inhibitors Market: Others (2017-2022) & (K Pcs)

Figure 24. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2017-2022)

Figure 25. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application in 2021

Figure 26. Histone Deacetylase (HDAC) Inhibitors Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Company in 2021

Figure 28. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Geographic Region in 2021

Figure 30. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2017-2022)

Figure 31. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country/Region in 2021

Figure 32. Americas Histone Deacetylase (HDAC) Inhibitors Sales 2017-2022 (K Pcs)

Figure 33. Americas Histone Deacetylase (HDAC) Inhibitors Revenue 2017-2022 ($ Millions)

Figure 34. APAC Histone Deacetylase (HDAC) Inhibitors Sales 2017-2022 (K Pcs)

Figure 35. APAC Histone Deacetylase (HDAC) Inhibitors Revenue 2017-2022 ($ Millions)

Figure 36. Europe Histone Deacetylase (HDAC) Inhibitors Sales 2017-2022 (K Pcs)

Figure 37. Europe Histone Deacetylase (HDAC) Inhibitors Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue 2017-2022 ($ Millions)

Figure 40. Americas Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country in 2021

Figure 41. Americas Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country in 2021

Figure 42. United States Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region in 2021

Figure 47. APAC Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Regions in 2021

Figure 48. China Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country in 2021

Figure 55. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country in 2021

Figure 56. Germany Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country in 2021

Figure 63. Egypt Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Histone Deacetylase (HDAC) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Histone Deacetylase (HDAC) Inhibitors in 2021

Figure 69. Manufacturing Process Analysis of Histone Deacetylase (HDAC) Inhibitors

Figure 70. Industry Chain Structure of Histone Deacetylase (HDAC) Inhibitors

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles